Ketoconazole Shampoo segmentation by application divides the market into three principal uses: medical (prescription) treatment of fungal scalp disorders, over‑the‑counter (OTC) management of dandruff and seborrheic dermatitis, and cosmetic or salon‑based hair‑care. The medical segment, driven by dermatologist prescriptions for conditions such as tinea capitis, accounts for roughly 45 % of total revenue, reflecting higher unit prices and insurance reimbursement. The OTC segment, which targets self‑treated dandruff, contributes about 35 % of sales; its volume is larger but average price is lower, resulting in a moderate share of the market size. The cosmetic/salon segment, comprising professional‑grade formulations used in hair‑loss prevention and scalp‑health services, represents the remaining 20 %. These proportions are illustrated in the accompanying pie chart. By isolating application, analysts can trace demand elasticity, regulatory impact, and channel‑specific growth patterns within the broader Ketoconazole Shampoo market.